086 – Kanserde PD-1 ve PD-L1
Burada birçok yayınımı paylaşmayı unuttuğum için eklemediğimi fark ettim. Bu nedenle makaleleri yayım sırasına göre numaralandırıyorum. Atladığım bir makale olmaması için. Bu numaralandırmaya kitap bölümü vb. dahil olmayacak.
Birçok kanserde önemli olan programlanmış hücre ölümü (PD)-1 proteini ve ligandı (PD-L1) üzerine yazılan yayınların bibliyometrik bir incelemesini yaptık.
Yazının tam metnine ulaşmak için burayı ziyaret edebilirsiniz.
Özet:
Background:
Bibliometrics has been used for assessing and predicting trends in macro-health science and medical systems, especially in the field of cancer. Bibliometric and scientometric studies in the field of programmed cell death 1/programmed cell death 1 ligand 1 (PD-1/PD-L1) may guide further research in this field.
Objective:
To perform bibliometric analysis of articles on PD-1 and PD-L1 published in the academic literature during 1975 to 2017.
Method:
The bibliometric analysis was performed using the Thomson Reuters Web of Science database.
Results:
A total of 23 813 articles were retrieved, 73.52% of which were original articles. The United States was the leading country by total publication number (n = 10 897, 10.91%), followed by China (10.54%), and produced the most literature on PD-1/PD-L1 (164.65 articles). Among the institutions identified, Harvard University (USA) contributed the most articles on PD-1/PD-L1.
Conclusions:
All authors and institutions in the top 10 contributor’s lists were from the developed countries. Researchers from the developing and least-developed countries should be encouraged to perform novel studies on PD-1 and PD-L1.
Keywords: PD-1, PD-L1, neoplasms, immunotherapy, bibliometrics
Atıf:
Baş Y, Şenel E. A Holistic Evaluation of Articles on PD-1 and PD-L1 Published Between 1975 and 2017: A Bibliometric Analysis. Cancer Inform. 2019 Jun 4;18:1176935119852620. doi: 10.1177/1176935119852620. PubMed PMID: 31210726; PubMed Central PMCID: PMC6552349.